From the Guardian · · 1m 50s
E coli toxin suspected in young bowel cancer rise
Scientists tell MPs a bacterial toxin called colibactin, produced by some E coli variants, may drive early-onset colorectal cancer in people under 50.
In brief
Scientists tell MPs a bacterial toxin called colibactin, produced by some E coli variants, may drive early-onset colorectal cancer in people under 50. Scientists identified colibactin, a toxin from some E coli bacteria, as a leading suspect in rising bowel cancer cases among people under fifty. Originally reported by…
Cases doubling in young people
Early-onset bowel cancer cases have doubled in many countries over the past two decades. Known risk factors like obesity, smoking and alcohol explain only about half of diagnoses.
Colibactin emerges as leading suspect

Scientists identified colibactin, a toxin produced by some E coli variants in the gut, as a potential driver of early-onset colorectal cancer.
Mutations appear in early childhood
Prof Mike Stratton at the Sanger Institute found colibactin causes mutations in some children as early as infancy. By age ten, affected children can have a similar mutational burden to a fifty-year-old.
Early exposure gives cancer a head start
Dr Karl Smith-Byrne of the University of Oxford explained that if colibactin causes mutations at a sensitive period in early life, it can give a person's colon or rectum a head start towards developing tumours.
Early life exposure hard to study
Prof Helen Coleman at Queen's University Belfast said colibactin was the first new clue in quite some time, but exposure likely occurred in very early childhood or even prenatally, making it very difficult to study.
At a glance
Scientists identified colibactin, a toxin from some E coli bacteria, as a leading suspect in rising bowel cancer cases among people under fifty.
Read the TL;DR — this story on one card.





